Elizabeth Dragon, Ph.D.

Senior Vice President, Research and Development

Dr. Dragon joined Sequenom as Senior Vice President of Research and Development in May 2006.  Dr. Dragon has over 25 years of diagnostics R&D, management, and leadership experience, including significant product development and commercialization planning and execution achievements during her tenure at Roche Molecular Systems from 1990 to 2006.  At Roche, Dr. Dragon held many leadership roles of increasing responsibility, most recently as Senior Vice President of Global Standardization and Vice President of Diagnostics Development. She pioneered the development and commercialization of PCR-based diagnostic tests and ultimately led the global commercialization of numerous FDA-approved diagnostic products. Her successes include the development and commercialization of the AMPLICOR(R), COBAS AMPLICOR(TM), COBAS AmpliPrep(TM), and COBAS TaqMAN(R) reagent product lines and their integration with system configurations for those reagents. Roche's molecular diagnostics sales revenues, including significant contribution from these product lines, were almost 1.2 billion Swiss francs (close to $1 billion U.S.) for 2005.  Dr. Dragon earned her Ph.D. in Virology and Cell Biology from Albert Einstein College of Medicine of Yeshiva University, is an author of numerous publications, and has received numerous awards, fellowships, and grants.